These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15316316)
1. CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors. Barbareschi M; Roldo C; Zamboni G; Capelli P; Cavazza A; Macri E; Cangi MG; Chilosi M; Doglioni C Am J Surg Pathol; 2004 Sep; 28(9):1169-76. PubMed ID: 15316316 [TBL] [Abstract][Full Text] [Related]
2. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Srivastava A; Hornick JL Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin. Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383 [TBL] [Abstract][Full Text] [Related]
5. NKX6-1 Is a Novel Immunohistochemical Marker for Pancreatic and Duodenal Neuroendocrine Tumors. Tseng IC; Yeh MM; Yang CY; Jeng YM Am J Surg Pathol; 2015 Jun; 39(6):850-7. PubMed ID: 25871618 [TBL] [Abstract][Full Text] [Related]
6. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms. Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824 [TBL] [Abstract][Full Text] [Related]
7. [Expression of Cdx-2 homeobox gene in intestinal metaplasia and gastric adenocarcinoma]. Paik CH; Han DS; Lee SH; Chung YW; Kim JP; Sohn JH; Hahm JS; Oh YH; Park YU Korean J Gastroenterol; 2004 Oct; 44(4):186-92. PubMed ID: 15505429 [TBL] [Abstract][Full Text] [Related]
8. CDX-2 expression in pulmonary fine-needle aspiration specimens: a useful adjunct for the diagnosis of metastatic colorectal adenocarcinoma. Levine PH; Joutovsky A; Cangiarella J; Yee H; Simsir A Diagn Cytopathol; 2006 Mar; 34(3):191-5. PubMed ID: 16470859 [TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors. Soukup J; Manethova M; Stejskal V; Hornychova H; Cesak T; Netuka D; Ryska A; Gabalec F Endocr Pathol; 2023 Sep; 34(3):333-341. PubMed ID: 37552455 [TBL] [Abstract][Full Text] [Related]
10. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary. Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909 [TBL] [Abstract][Full Text] [Related]
11. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression. Rossi G; Murer B; Cavazza A; Losi L; Natali P; Marchioni A; Migaldi M; Capitanio G; Brambilla E Am J Surg Pathol; 2004 Apr; 28(4):442-52. PubMed ID: 15087663 [TBL] [Abstract][Full Text] [Related]
12. Expression of cadherin 17 in well-differentiated neuroendocrine tumours. Snow AN; Mangray S; Lu S; Clubwala R; Li J; Resnick MB; Yakirevich E Histopathology; 2015 Jun; 66(7):1010-21. PubMed ID: 25388236 [TBL] [Abstract][Full Text] [Related]
13. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Oliveira AM; Tazelaar HD; Myers JL; Erickson LA; Lloyd RV Am J Surg Pathol; 2001 Jun; 25(6):815-9. PubMed ID: 11395561 [TBL] [Abstract][Full Text] [Related]
14. Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors. Wang YC; Gallego-Arteche E; Iezza G; Yuan X; Matli MR; Choo SP; Zuraek MB; Gogia R; Lynn FC; German MS; Bergsland EK; Donner DB; Warren RS; Nakakura EK Endocr Relat Cancer; 2009 Mar; 16(1):267-79. PubMed ID: 18987169 [TBL] [Abstract][Full Text] [Related]
16. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions. Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871 [TBL] [Abstract][Full Text] [Related]
17. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Werling RW; Yaziji H; Bacchi CE; Gown AM Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886 [TBL] [Abstract][Full Text] [Related]
18. CDX-1 and CDX-2 are expressed in human colonic mucosa and are down-regulated in patients with Hirschsprung's disease associated enterocolitis. Lui VC; Li L; Sham MH; Tam PK Biochim Biophys Acta; 2001 Sep; 1537(2):89-100. PubMed ID: 11566252 [TBL] [Abstract][Full Text] [Related]
19. The Cdx-1 and Cdx-2 homeobox genes in the intestine. Freund JN; Domon-Dell C; Kedinger M; Duluc I Biochem Cell Biol; 1998; 76(6):957-69. PubMed ID: 10392709 [TBL] [Abstract][Full Text] [Related]
20. Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation. Nakayama C; Yamamichi N; Tomida S; Takahashi Y; Kageyama-Yahara N; Sakurai K; Takeuchi C; Inada KI; Shiogama K; Nagae G; Ono S; Tsuji Y; Niimi K; Fujishiro M; Aburatani H; Tsutsumi Y; Koike K Cancer Sci; 2018 Dec; 109(12):3853-3864. PubMed ID: 30289576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]